Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.

Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation: a Single-center Experience.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05134090

Enrollment

Registered

2021-11-24

Start date

2021-05-10

Completion date

2021-08-01

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility Issues, Oncology, Surgery

Keywords

Percuvataneous laparoscopy, Ovarian Tissue Cryopreservation

Brief summary

To compare surgical outcomes of oncologic patients that underwent conventional laparoscopy and percutaneous laparoscopy for cryopreservation of ovarian tissue.

Detailed description

This is a retrospective analysis to evaluate the efficacy and safety of percutaneous laparoscopy for the ovarian tissue explant in oncologic women. Surgical outcomes of patients that underwent percutaneous laparoscopy were compared with those of women that underwent conventional laparoscopy. Data from 2017 to 2021 were collected in a single Oncologic Center in Italy. The principal outcomes considered are post-operative pain, recovery time and aesthetic outcomes.

Interventions

DEVICEOvaian tissue explant

Ovarian tissue explant for cryopreservation of ovarian tissue

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 42 Years

Healthy volunteers

Yes

Inclusion criteria

* Oncologic women with desire to preserve fertility

Exclusion criteria

* Ovarian explant with different techniques than laparoscopy

Design outcomes

Primary

Measure	Time frame	Description
Post-operative pain	0-1 and 2 days after surgery	Post-operative pain is evaluated with VAS score ranging from 1 to 10 (higher score, maximum pain)
Aesthetic outcomes	minimum 3 months after surgery	General satisfaction regarding aesthetic outcomes is collected with a satisfaction survey. The score ranged from 1 to 5, with 1 indicating very dissatisfied and 5 very satisfied.

Secondary

Measure	Time frame	Description
Recovery time	Days	Time from surgical intervention to discharge in days
Operative time	1 day	Time of operation in minutes
Blood loss	1 day	Entity of blood loss during surgery in ml
Surgical complications	30 days	The presence of absence of intra and post-operative complications (yes or not and type)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026